CT
private_company

CRISPR Therapeutics

CRISPR Therapeutics is an investor based in Switzerland, investing in Healthcare & Life Sciences, Genomics & Molecular Biology and Pharmaceutical Development, 2 tracked investments.

2
Investments Tracked

About CRISPR Therapeutics

CRISPR Therapeutics is an investor headquartered in Switzerland. We have recorded 2 investments for CRISPR Therapeutics to date.

Sector activity concentrates in Healthcare & Life Sciences, Genomics & Molecular Biology, Pharmaceutical Development and Synthetic Biology. Coverage extends to 8 sectors in total. Participation spans Series A and Series C+ rounds.

CRISPR Therapeutics is focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company is applying this technology platform to research, develop and commercialize medicines for various diseases.

Investment Focus

Stage Focus
series-aseries-c-plus
Sectors
Healthcare & Life SciencesGenomics & Molecular Biologypharmaceutical-developmentsynthetic biologytherapeuticsgene-therapyaisynthetic-biology

Investment Thesis

CRISPR Therapeutics is focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company is applying this technology platform to research, develop and commercialize medicines for various diseases.

Team

Samarth Kulkarni

Explore CRISPR Therapeutics's full profile on Brouky

Portfolio companies, co-investors, AI match scores, and deal flow signals.

Other Investors in Switzerland

Other Investors in Healthcare & Life Sciences / Genomics & Molecular Biology